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This volume contains the proceedings of Nobel Symposium 90, "Mitochondrial 
Diseases", which took place in SaltsjSbaden, Sweden between July 2 and 6, 1994. 
Since 1965, the Nobel Foundation has sponsored a number of symposia in areas of 
great scientific importance in which recent progress of particular interest has been made. 
The study of mitochondrial diseases is such an area, and it therefore appeared timely to 
organize a Nobel Symposium on this subject. 
The first mitochondrial disease, subsequently referred to as "Luft's Disease", was 
described uring the years 1959 to 1963, as the result of a collaboration between the 
Department of Endocrinology, Karolinska Institutet, and the Wenner-Gren Institute for 
Experimental Biology, University of Stockholm. It was a case of severe hyperme- 
tabolism of non-thyroid origin, with a defect of the patient's keletal muscle mito- 
chondria to maintain respiratory control. This discovery marked the beginning of what 
Rolf Luft in the Opening Lecture of this Symposium described as "The Development of
Mitochondrial Medicine". 
The number of reports on mitochondrial diseases has been increasing exponentially 
over the last three decades. Initially this development was due mainly to refined 
techniques for the preparation and the morphological and biochemical analysis of 
mitochondria from human biopsy specimens. Following the discovery of mitochondrial 
DNA in the early 1960s, a major breakthrough in this area occurred in the 1980s through 
the sequencing of human mitochondrial DNA and the invention of the PCR method 
which made possible the identification of mitochondrial DNA mutations in very small 
tissue specimens. Another highly important advance during the same period was the 
development of 31 P-NMR and other noninvasive spectroscopic methods for the determi- 
nation of the energy state of various tissues in situ. 
Due to the above developments, he study of mitochondrial diseases represents oday 
a highly active field of research. It has opened new insights, not only into the 
pathogenesis of these diseases, but also into the biological function of mitochondria at 
large. In addition to the concept of mitochondria serving as the "powerhouse" of the 
cell, it is now evident hat this organelle plays a strategic role in the genetic regulation of 
cellular energy metabolism, with important implications for various biological functions 
such as the interaction of the mitochondrial nd nuclear genomes, intracellular protein 
transport, Ca 2+ homeostasis, cellular signalling mechanisms, antioxidant and immune 
defences. There is growing evidence that a large number of pathological conditions, 
including various myo- and neuropathies, degenerative diseases uch as cardiovascular 
diseases and certain forms of cancer, autoimmune diseases, may have their origin in 
mitochondrial dysfunction. Some of these aspects were highlighted by Gottfried Schatz 
in his Keynote Lecture ntitled "Mitochondria: Oxidative Phosphorylation a d Beyond". 
At present, the research in mitochondrial diseases extends over a wide area of 
scientific disciplines, encompassing biophysics, biochemistry, molecular and cell biol- 
ogy, physiology, genetics, immunology, pharmacology, toxicology and clinical medicine. 
The purpose of the present Symposium was to bring together scientists from different 
parts of the world and with different interests in this field to exchange results and ideas 
within each other's specialities. In view of the pronouncedly interdisciplinary nature of 
the field, there is also a trend of specialization within the individual disciplines. Some 
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research groups concentrate their interest on the bioenergetic, others on the molecular- 
biological, and again others on the pharmacological-toxicological and clinical-physio- 
logical aspects. The present Symposium was hoped to promote a much-needed integra- 
tion of professional and intellectual resources within these various areas. The pro- 
gramme of the Symposium included, in addition to the Opening and Keynote Lectures, 
seven sessions, with four to six 30-minute lectures followed by a 45-minute panel 
discussion in each session. The topics of the sessions are indicated in the Table of 
Contents of this volume. The outcome of the Symposium, in the form of lectures, 
discussions and the papers included in this volume, more than fulfilled our expectations, 
and we extend our heartfelt hanks to all participants for their contributions. 
The Symposium was attended by 63 participants, including invited chairpersons, 
speakers and observers from 12 countries, as well as administrative and technical staff. 
The names and affiliations of the participants are listed as an annex to this Preface. We 
wish to express our warmest thanks to Kerstin Nordenbrand for her excellent service as 
Symposium Secretary, extending from the early planning phase throughout the Sympo- 
sium and the subsequent preparation of this volume. We also thank Kicki Svennersji5 
and Ann Nielsen-Lundgren for valuable administrative assistance, and Patrik Andr6e, 
Ronggui Li and Patrik Wollberg for skilful technical help during the Symposium. 
We want to express our special thanks to Professor George K. Radda, former 
Executive Editor of Biochimica et Biophysica Acta, Section of Molecular Basis of 
Disease, for making possible the publication of the Symposium in this Journal, and for 
his most valuable editorial advice. Our thanks are also due to the staff of Elsevier 
Science B.V., for their friendly and efficient cooperation. 
Finally, we wish to express our gratitude to the Nobel Foundation for sponsoring a
symposium on this highly topical field of research with deep roots in Sweden. 
Lars Ernster Rolf Luft Sten Orrenius 
